Article

Preoperative circulating tumor DNA level is associated to poor overall survival in patients with ovarian cancer

2022-07-15

Abstract excerpt

<title>Abstract</title> <p>Background Circulating tumor DNA (ctDNA), which is shed from tumor cells into the blood, is a promising minimal-invasive method for cancer diagnostics and monitoring. The aim of this study was to evaluate preoperative ctDNA levels in the plasma of patients with ovarian cancer and correlate the levels to clinicopathological parameters and patient outcome. Methods Tumor DNA was extracte...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: a07c2fa8-9229-501c-892a-c99ede2e014a
DOI: 10.21203/rs.3.rs-1770497/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Preoperative circulating tumor DNA level is associated to poor overall survival in patients with ovarian cancerDOI 10.21203/rs.3.rs-1770497/v1Read

Preoperative ctDNA Levels Are Associated With Poor Overall Survival in Patients With Ovarian Cancer.Semantic proximity Read

Mutations in circulating tumor DNA detected in the postoperative period predict poor survival in patients with ovarian cancer.Semantic proximity Read

Comprehensive Gene Mutation Profiling of Circulating Tumor DNA in Ovarian Cancer: Its Pathological and Prognostic ImpactSemantic proximity Read

Circulating Tumor DNA (ctDNA) and Its Role in Gynecologic Malignancies.Semantic proximity Read

Advances in application of circulating tumor DNA in ovarian cancer.Semantic proximity Read

Clinical Implications of Circulating Tumor DNA from Ascites and Serial Plasma in Ovarian Cancer.Semantic proximity Read

Clinical implications of plasma circulating tumor DNA in gynecologic cancer patients.Semantic proximity Read

Detection of circulating tumor DNA in patients of operative colorectal and gastric cancersSemantic proximity Read

Circulating tumor DNA: a noninvasive biomarker for tracking ovarian cancerSemantic proximity Read

Circulating tumor DNA monitoring for early recurrence detection in epithelial ovarian cancer.Semantic proximity Read

Serial Circulating Tumor DNA Analysis with a Tumor-Naïve Next-Generation Sequencing Panel Detects Minimal Residual Disease and Predicts Outcome in Ovarian Cancer.Semantic proximity Read

Exploratory Analysis of TP53 Mutations in Circulating Tumour DNA as Biomarkers of Treatment Response for Patients with Relapsed High-Grade Serous Ovarian Carcinoma: A Retrospective Study.Semantic proximity Read